1,438 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Tuesday’s Close
AMGN Amgen Inc. $200.81 $129.98B Uptrend
Article Searches
Is Now A Good Time To Buy Amgen? https://seekingalpha.com/article/4207875-now-good-time-buy-amgen?source=feed_sector_healthcare Sep 24, 2018 - Amgen is a high-quality business generating strong cash flows.Valuation is fairly reasonable.Earnings expectations are increasing.Winners tend to keep on winning in the stock market, and Amgen is deli
Gritstone Oncology Prepares Final Terms For IPO https://seekingalpha.com/article/4207599-gritstone-oncology-prepares-final-terms-ipo?source=feed_sector_healthcare Sep 21, 2018 - Gritstone Oncology intends to raise $85 million from the sale of its common stock in an IPO.The firm is advancing immunotherapy-based cancer treatments using its proprietary AI-driven platform.GRTS wi
AbbVie Faces California Insurance Department Suit for Humira http://www.zacks.com/stock/news/323897/abbvie-faces-california-insurance-department-suit-for-humira?cid=CS-ZC-FT-323897 Sep 19, 2018 - AbbVie's (ABBV) shares fall on a lawsuit by California insurance department accusing it of giving illegal kickbacks to doctors for prescribing Humira.
GameStop's Fundamentals Are Declining - Cramer's Lightning Round (9/18/18) https://seekingalpha.com/article/4207068-gamestops-fundamentals-declining-cramers-lightning-round-9-18-18?source=feed_tag_cramers_picks Sep 19, 2018 - Regeneron and Amgen are better picks than Biogen.The refiners are doing well.Book profits on Liberty Oilfield Services.
AstraZeneca's Fasenra Long-Term Asthma Study Data Positive http://www.zacks.com/stock/news/323891/astrazenecas-fasenra-long-term-asthma-study-data-positive?cid=CS-ZC-FT-323891 Sep 19, 2018 - AstraZeneca's (AZN) asthma drug, Fasenra, maintains improvements achieved over first year of treatment in severe eosinophilic asthma patients for the next 56 weeks.
The Zacks Analyst Blog Highlights: UnitedHealth, Adobe, Amgen, UPS and Bayer http://www.zacks.com/stock/news/323491/the-zacks-analyst-blog-highlights-unitedhealth-adobe-amgen-ups-and-bayer?cid=CS-ZC-FT-323491 Sep 18, 2018 - The Zacks Analyst Blog Highlights: UnitedHealth, Adobe, Amgen, UPS and Bayer
3 High-Quality Biotech Companies for 4th Quarter http://www.gurufocus.com/news/740841/3-highquality-biotech-companies-for-4th-quarter Sep 17, 2018 - 3 High-Quality Biotech Companies for 4th Quarter, Stocks: BIIB,GILD,NVO,BRK.A,BRK.B,AMGN,CELG, Warren Buffett, release date:Sep 17, 2018
Teva Investors Get Headache Relief https://www.wsj.com/articles/teva-investors-get-headache-relief-1537200489?mod=rss_Technology Sep 17, 2018 - A new migraine drug is a big win amid the turnaround of generics business.
Top Research Reports for UnitedHealth, Adobe & Amgen http://www.zacks.com/research-daily/182358/top-research-reports-for-unitedhealth-adobe-amgen?cid=CS-ZC-FT-182358 Sep 17, 2018 - Top Research Reports for UnitedHealth, Adobe & Amgen
Is Now a Good Time to Buy Amgen? https://www.fool.com/investing/2018/09/15/is-now-a-good-time-to-buy-amgen.aspx?source=iedfolrf0000001 Sep 15, 2018 - Amgen's shares are rallying, but there are some risks that every investor ought to consider.

Pages: 123456...144

Page 1>

Related Companies

Name Exchange Price Mkt Cap
GILD Gilead Sciences, Inc. NASDAQ $72.78 $94.35B
BIIB Biogen Inc. NASDAQ $334.44 $67.37B
SGEN Seattle Genetics, Inc. NASDAQ $76.15 $12.09B
NBIX Neurocrine Biosciences, Inc. NASDAQ $117.38 $10.62B
QGEN Qiagen N.V. NASDAQ $37.42 $8.5B
Sector: Health Care > Industry: Biotechnology: Biological Products (No Diagnostic Substances)
DeepLinks for Amgen